VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.1
(0.05%)
USD 0.1
(0.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.97 Million CAD | -1.25% |
| 2022 | 4.96 Million CAD | 33.73% |
| 2021 | 3.71 Million CAD | 93.98% |
| 2020 | 1.91 Million CAD | -42.31% |
| 2019 | 3.31 Million CAD | -13.75% |
| 2018 | 3.84 Million CAD | 13.52% |
| 2017 | 3.39 Million CAD | 66.69% |
| 2016 | 2.03 Million CAD | 2.07% |
| 2015 | 1.99 Million CAD | 0.55% |
| 2014 | 1.98 Million CAD | -39.55% |
| 2013 | 3.27 Million CAD | -37.02% |
| 2012 | 5.2 Million CAD | 24.92% |
| 2011 | 4.16 Million CAD | 78.65% |
| 2010 | 2.33 Million CAD | 40.81% |
| 2009 | 1.65 Million CAD | -67.25% |
| 2008 | 5.05 Million CAD | 220.04% |
| 2007 | 1.58 Million CAD | 3665.55% |
| 2006 | 41.97 Thousand CAD | -59.47% |
| 2005 | 103.56 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.39 Million CAD | 22.14% |
| 2024 Q1 | 1.15 Million CAD | -8.57% |
| 2023 Q4 | 1.26 Million CAD | 9.73% |
| 2023 Q1 | 1.36 Million CAD | 19.97% |
| 2023 FY | 4.9 Million CAD | -1.25% |
| 2023 Q2 | 1.11 Million CAD | -18.45% |
| 2023 Q3 | 1.15 Million CAD | 3.87% |
| 2022 Q4 | 1.13 Million CAD | -21.48% |
| 2022 FY | 4.96 Million CAD | 33.73% |
| 2022 Q1 | 1.04 Million CAD | -12.34% |
| 2022 Q2 | 1.34 Million CAD | 28.94% |
| 2022 Q3 | 1.44 Million CAD | 7.51% |
| 2021 Q2 | 891.3 Thousand CAD | 0.21% |
| 2021 Q3 | 744.81 Thousand CAD | -16.44% |
| 2021 FY | 3.71 Million CAD | 93.98% |
| 2021 Q4 | 1.18 Million CAD | 59.75% |
| 2021 Q1 | 889.45 Thousand CAD | 32.84% |
| 2020 Q2 | 321.18 Thousand CAD | -8.27% |
| 2020 Q4 | 669.54 Thousand CAD | 16.55% |
| 2020 FY | 1.91 Million CAD | -42.31% |
| 2020 Q3 | 574.49 Thousand CAD | 78.86% |
| 2020 Q1 | 350.14 Thousand CAD | -42.99% |
| 2019 FY | 3.31 Million CAD | -13.75% |
| 2019 Q1 | 1.05 Million CAD | 12.24% |
| 2019 Q2 | 876.42 Thousand CAD | -17.05% |
| 2019 Q4 | 614.2 Thousand CAD | -20.52% |
| 2019 Q3 | 772.77 Thousand CAD | -11.83% |
| 2018 Q2 | 1.1 Million CAD | 22.72% |
| 2018 Q1 | 898.57 Thousand CAD | -13.01% |
| 2018 FY | 3.84 Million CAD | 13.52% |
| 2018 Q4 | 941.35 Thousand CAD | 3.81% |
| 2018 Q3 | 906.78 Thousand CAD | -17.77% |
| 2017 Q4 | 1.03 Million CAD | -12.45% |
| 2017 FY | 3.39 Million CAD | 66.69% |
| 2017 Q3 | 1.17 Million CAD | 79.12% |
| 2017 Q2 | 658.63 Thousand CAD | 22.64% |
| 2017 Q1 | 537.03 Thousand CAD | 25.88% |
| 2016 Q1 | 565.02 Thousand CAD | -7.88% |
| 2016 Q2 | 621.96 Thousand CAD | 10.08% |
| 2016 Q3 | 435.59 Thousand CAD | -29.97% |
| 2016 FY | 2.03 Million CAD | 2.07% |
| 2016 Q4 | 426.63 Thousand CAD | -2.06% |
| 2015 Q3 | 347.49 Thousand CAD | -32.69% |
| 2015 FY | 1.99 Million CAD | 0.55% |
| 2015 Q1 | 447.43 Thousand CAD | -35.16% |
| 2015 Q2 | 516.3 Thousand CAD | 15.39% |
| 2015 Q4 | 613.35 Thousand CAD | 76.5% |
| 2014 Q3 | 605.3 Thousand CAD | 61.09% |
| 2014 Q1 | 290.87 Thousand CAD | -67.8% |
| 2014 FY | 1.98 Million CAD | -39.55% |
| 2014 Q4 | 690.02 Thousand CAD | 14.0% |
| 2014 Q2 | 375.75 Thousand CAD | 29.18% |
| 2013 Q4 | 903.2 Thousand CAD | 7.91% |
| 2013 Q2 | 713.32 Thousand CAD | -13.86% |
| 2013 Q1 | 828.09 Thousand CAD | -42.49% |
| 2013 FY | 3.27 Million CAD | -37.02% |
| 2013 Q3 | 836.97 Thousand CAD | 17.33% |
| 2012 FY | 5.2 Million CAD | 24.92% |
| 2012 Q3 | 1.43 Million CAD | 17.38% |
| 2012 Q2 | 1.22 Million CAD | 5.76% |
| 2012 Q1 | 1.15 Million CAD | 19.84% |
| 2012 Q4 | 1.43 Million CAD | 0.11% |
| 2011 Q2 | 959.05 Thousand CAD | 13.58% |
| 2011 FY | 4.16 Million CAD | 78.65% |
| 2011 Q4 | 966.72 Thousand CAD | -16.29% |
| 2011 Q3 | 1.15 Million CAD | 20.41% |
| 2011 Q1 | 844.41 Thousand CAD | 15.4% |
| 2010 Q2 | 598.84 Thousand CAD | 164.55% |
| 2010 Q3 | 786.02 Thousand CAD | 31.26% |
| 2010 FY | 2.33 Million CAD | 40.81% |
| 2010 Q4 | 731.7 Thousand CAD | -6.91% |
| 2010 Q1 | 226.36 Thousand CAD | -48.15% |
| 2009 Q4 | 436.6 Thousand CAD | 82.62% |
| 2009 FY | 1.65 Million CAD | -67.25% |
| 2009 Q2 | 420.05 Thousand CAD | -40.18% |
| 2009 Q1 | 702.24 Thousand CAD | -61.28% |
| 2009 Q3 | 239.07 Thousand CAD | -43.08% |
| 2008 Q1 | 829.07 Thousand CAD | -0.69% |
| 2008 Q4 | 1.81 Million CAD | 45.88% |
| 2008 Q2 | 1.1 Million CAD | 33.26% |
| 2008 Q3 | 1.24 Million CAD | 12.54% |
| 2008 FY | 5.05 Million CAD | 220.04% |
| 2007 Q3 | 344.11 Thousand CAD | 6041.11% |
| 2007 Q4 | 834.8 Thousand CAD | 142.59% |
| 2007 FY | 1.58 Million CAD | 3665.55% |
| 2007 Q2 | 5603.53 CAD | -87.75% |
| 2007 Q1 | 45.72 Thousand CAD | 106.44% |
| 2006 Q1 | 9992.07 CAD | 0.0% |
| 2006 Q4 | 22.15 Thousand CAD | 488.64% |
| 2006 Q3 | 3762.94 CAD | -37.95% |
| 2006 FY | 41.97 Thousand CAD | -59.47% |
| 2006 Q2 | 6064.59 CAD | -39.31% |
| 2005 FY | 103.56 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| IR-Med Inc. | 4.89 Million USD | -1.613% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -571.405% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -276.596% |
| Polarean Imaging plc | 12.24 Million USD | 59.38% |
| Avitar, Inc. | 3.56 Million USD | -39.317% |
| AVITA Medical, Inc. | 80.77 Million USD | 93.844% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -607.387% |
| Össur hf. | 396.18 Million USD | 98.745% |
| Zecotek Photonics Inc. | 3.46 Million USD | -43.666% |
| QHSLab, Inc. | 961.65 Thousand USD | -417.123% |
| Wellstar International, Inc. | 1.79 Million USD | -177.09% |
| Össur hf. | 396.18 Million USD | 98.745% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 77.165% |
| Escalon Medical Corp. | 5.25 Million USD | 5.29% |
| Aurora Spine Corporation | 8.65 Million USD | 42.559% |
| BrainsWay Ltd. | 28.01 Million USD | 82.251% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 48.005% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 85.188% |
| Vivos Inc. | 2.78 Million USD | -78.426% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.526% |
| Kelyniam Global, Inc. | 2.27 Million USD | -118.567% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -389.991% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -1041.89% |
| Nanomix Corporation | 8.36 Million USD | 40.57% |
| Theraclion SA | 7.43 Million USD | 33.158% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -284.135% |
| Positron Corporation | 1 Million USD | -393.697% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -59.878% |
| Lombard Medical, Inc. | 30.29 Million USD | 83.582% |
| ALR Technologies Inc. | 6.33 Million USD | 21.513% |
| Stratec SE | 46.32 Million USD | 89.264% |
| Vycor Medical, Inc. | 1.27 Million USD | -289.892% |
| Heart Tronics, Inc. | 14.46 Million USD | 65.609% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -4026.024% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -2309.145% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 64.858% |
| VMS Rehab Systems, Inc. | 63.63 USD | -7815288.967% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -42.369% |
| Ingen Technologies, Inc. | 1.88 Million USD | -164.206% |
| Odyssey Group International, Inc. | -14.26 Million USD | 134.871% |
| United American Healthcare Corporation | 59 Thousand USD | -8328.698% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -1120.396% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -683.524% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -193.291% |
| Urologix, Inc. | 10.09 Million USD | 50.724% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -293.636% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 16.397% |
| SS Innovations International, Inc. | 21.38 Million USD | 76.742% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -2059.881% |
| Smith & Nephew plc | 3.46 Billion USD | 99.857% |
| NIOX Group Plc | 22.27 Million USD | 77.677% |
| Fuse Medical, Inc. | 10.35 Million USD | 51.952% |
| Broncus Holding Corporation | 38.15 Million USD | 86.965% |
| Brain Scientific Inc. | 9.66 Million USD | 48.535% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 51.733% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -8092.909% |